Windlas Biotech Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Limited regarding scheduled meetings with investors and analysts. The disclosure is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company officials will be conducting virtual one-on-one meetings with the following institutional investors according to the specified schedule:
- Thursday, July 2, 2026: Trust Mutual Fund at 3:30 PM
- Friday, July 3, 2026: Baring Private Equity Partners India at 11:00 AM
- Tuesday, July 7, 2026: Vaikarya Investment Management at 3:00 PM
- Tuesday, July 7, 2026: UT Mutual Fund at 4:00 PM
The company explicitly states that all discussions during these meetings will reference only publicly available documents, and no unpublished price sensitive information (UPSI) will be shared. The disclosure notes that changes to the schedule may occur due to exigencies on the part of investors, analysts, or the company.
The letter is signed by Ananta Narayan Panda, Company Secretary & Compliance Officer of Windlas Biotech Limited, and includes the company's registration details (CIN-L74899UR2001PLC033407) and contact information for both registered office in Dehradun, Uttarakhand and corporate office in Gurgaon, Haryana.